Stocks Health care IVF
NASDAQ · Health careINVO Fertility, Inc. (IVF)
INVO Fertility, Inc. brought in $7.5M of revenue over the twelve months to June 30, 2026, up 13.1% from a year earlier. It posted a net loss of $7M. In fiscal 2025 capital spending exceeded operating cash flow by $7.1M. At June 30, 2026 it held $3.7M in cash against $1.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch IVF in 60 secondsWhat INVO Fertility, Inc. does
INVO Fertility, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IVF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $6.8M | -$23.3M | -$214.64 | -$7.1M |
| 2024 | $6.6M | -$9.3M | -$3,782.65 | -$3.2M |
| 2023 | $3M | -$8M | -$8,441.11 | -$5.2M |
| 2022 | $822.2K | -$10.9M | -$29,568.57 | -$6.6M |
| 2021 | $4.2M | -$6.7M | -$20,698.00 | -$6.4M |
| 2020 | $1M | -$8.3M | -$49,938.03 | -$4.8M |
Full financial statements: income, balance sheet and cash flow
Where IVF ranks in Health care
Latest SEC filings
What INVO Fertility, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026
- August 28, 2026
- August 17, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 17% to $2.2M versus the same quarter last year; diluted EPS $0.35 versus -$364.23.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 7, 2026
- July 24, 2026IPO registration S-1
- July 24, 2026
- June 25, 2026
Who owns IVF
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Alumni Capital LP13G, passive with 2 related filers | 9.99% | August 7, 2026 |
| Glenbrook Capital Management13G, passive | 8.33% | April 1, 2026 |
Largest institutional holders
Insiders
Questions about IVF
What does INVO Fertility, Inc. do?
INVO Fertility, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IVF.
Is INVO Fertility, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $7M on revenue of $7.5M.
How much revenue does INVO Fertility, Inc. make?
Over the twelve months to June 30, 2026 INVO Fertility, Inc. reported revenue of $7.5M. That is 13.1% more than a year earlier.
When did INVO Fertility, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from August 28, 2026.
Similar companies
Compare IVF with
Follow IVF
Get an email when INVO Fertility, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow IVF: get an email when it filesWhere the numbers come from
Financial figures are the values INVO Fertility, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.